Drug Search Results
More Filters [+]

INDOLE-3-PROPIONIC ACID

Alternative Names: indole-3-propionic acid
Latest Update: 2024-11-28
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: 3M Health Care
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for INDOLE-3-PROPIONIC ACID

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Cerebellar Ataxia|Friedreich Ataxia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

iPROACT-pilot

N/A

Recruiting

Inflammation|Brain Diseases, Metabolic|Type 2 Diabetes

2025-04-01

NCT01898884

P1

Completed

Friedreich Ataxia|Cerebellar Ataxia

2015-06-18

Recent News Events